Evidence-based review and clinical practice recommendations for the diagnosis and management of common oral mucosal lesions

Table 1 Clinical classification of common oral mucosal lesions based on appearance, site, and risk profile

Lesion type	Common sites	Typical appearance	Differential diagnosis	Risk groups	Initial diagnostic approach	Ref.
Leukoplakia	Buccal mucosa, tongue, floor of mouth	White plaque, non-removable, asymptomatic	Frictional keratosis, oral lichen planus, candidiasis	Smokers or tobacco chewing users, the elderly, and alcohol users	Clinical exam + biopsy mandatory to determine the degree of dysplasia	[1,16-18]
Oral lichen planus	Buccal mucosa, gingiva, tongue	White striae (Wickham’s), erythematous, or erosive lesions	Lupus, leukoplakia, lichenoid drug reaction	Middle-aged adults, females > males	Clinical history + biopsy with immunofluorescence	[1,5,27,28,31]
Erythroplakia	Floor of the mouth, soft palate, tongue	Red, velvety lesion, well-demarcated	Inflammation, trauma, erosive lichen planus	Tobacco/alcohol users, the elderly	Urgent biopsy (90% show dysplasia or carcinoma)	[2,6,18,20]
Traumatic ulcer	Anywhere in occlusal or prosthetic trauma zones	Painful ulcer with red halo, irregular margins	Aphthous ulcer, SCC, syphilitic chancre	All age groups, especially denture wearers	History + remove cause; reassess in 2 weeks	[1,13,19,26]
Oral candidiasis, including angular cheilitis	Tongue, palate, buccal mucosa, oral commissures	White patches that can be wiped off, red areas, burning sensation, fissures at the oral commissures (angular cheilitis)	Leukoplakia, lichen planus, geographic tongue	Immunocompromised, denture users, diabetics	Swab for culture; response to antifungals such as nystatin (Nystan®) confirms diagnosis	[1,2,8,24]

SCC: Squamous cell carcinoma.

Table 2 Evidence-based first-line treatments and adjunct therapies for common oral mucosal conditions

Condition	First-line treatment	Dosage and frequency	Treatment duration	Adjunct therapy	Ref.	Evidence level (GRADE)
Aphthous ulcers	Betamethasone sodium phosphate 0.5 mg tablets dissolved in water (Betnesol® mouthwash)	Rinse 4 times/day QID	7-10 days or until complete symptom resolution; reassess at 10 days if persistent	Chlorhexidine gluconate 0.2% (Corsodyl®), Benzydamine hydrochloride 0.15% (Difflam®), topical lidocaine (Acuvisc®)	[1,12-15]	A
Oral lichen planus	Clobetasol propionate 0.05% ointment (Dermovate®). If not working: Tacrolimus 0.03% ointment (Protopic®)1	Apply a thin layer BID after meals. Apply 4 times daily	2-4 weeks, then mandatory reassessment; discontinue if no improvement after 4 weeks	Benzydamine hydrochloride 0.15% (Difflam®), nystatin suspension if fungal co-infection	[1,12-15]	A
Oral candidiasis including (angular cheilitis)	Nystatin oral suspension 100000 units/mL (Nystan®) or miconazole 2% oral gel (Daktarin®)	1 mL QID (hold in mouth, then swallow; dietary support)	7-14 days; continue 48 hours after clinical resolution; reassess at day 16 if ongoing	Vitamin B12 or iron supplementation; because nutritional deficiencies (iron, vitamin B12) provoke Candida albicans infection	[1,12-15]	A
Traumatic ulcers	Remove traumatic source (e.g., denture adjustment)	NA	Reassess at 10-14 days; biopsy if not fully healed by day 14	Lidocaine 2% gel (Acuvisc®), Chlorhexidine gluconate (Corsodyl®), Benzydamine hydrochloride (Difflam®)	[1,12-15]	A
Herpetic stomatitis	Aciclovir 200 mg tablets	Five times daily for 5 days	Complete 5-day course; review at day 7 if lesions persist	Benzydamine hydrochloride rinse (Difflam®), hydration, analgesics	[1,12-15]	A

¹Off-label use on oral mucosa; specialist initiation recommended. Evidence level (GRADE): A: High; B: Moderate; C: Low. BID: Twice a day; QID: Four times a day; NA: Not available.

Table 3 Systemic and adjunctive oral conditions: Diagnostic pathways and medical management

Condition	Diagnostic approach	First-line treatment	Dosage and frequency	Follow-up plan	Ref.	Evidence level (GRADE)
Oral candidiasis, including angular cheilitis	Oral swab for culture, assess risk factors (e.g., dentures, diabetes)	Nystatin oral suspension 100000 units/mL (Nystan®) or miconazole 2% oral gel (Daktarin®)	1 mL QID (hold in mouth then swallow)	Continue 48 h after resolution; reassess if unresponsive	[12-15]	A
Burning mouth syndrome (stage 1)	Swab to rule out Candida; blood test for vitamin B12, ferritin, folic acid	Correct underlying deficiency: Ferrous fumarate 200 mg (Fersaday®), Cyanocobalamin 1 mg (Cytacon®), folic acid 5 mg	Iron TID; vitamin B12 daily; folic acid daily	Repeat blood work in 3-4 weeks; escalate to stage 2 if unresolved	[12-15]	A
Burning mouth syndrome (stage 2)	Diagnosis of exclusion	Amitriptyline hydrochloride (generic)1; titrate cautiously	10-25 mg nocte; titrate slowly over 2-4 weeks	Review every 2-4 weeks; refer if no response by 8 weeks	[12-15]	A
Geographic tongue (migrating glossitis)	Clinical diagnosis: Assess for fungal co-infection	Miconazole 2% + hydrocortisone 1% cream (Daktacort®)	Apply BID for up to 7 days	Stop after 7 days or symptom relief; review at 2 weeks	[12-15]	A
Xerostomia	Medication history, salivary flow rate	Artificial saliva (Glandosane®) or Pilocarpine hydrochloride	Pilocarpine 5 mg TID (specialist only)	Manage oral hygiene, identify the underlying cause. Review salivary flow at 4 weeks; discontinue if no benefit	[12-15]	A

¹Off-label for neuropathic oral pain. Evidence level (GRADE): A: High; B: Moderate; C: Low. BID: Twice a day; TID: Three times a day; QID: Four times a day; Nocte: At night.

Table 4 Severity-based escalation protocol for common oral mucosal lesions in general dental practice

Severity level	Clinical indicators	First-Line management	Escalated treatment (if unresponsive)	Referral criteria	Ref.	Evidence level (GRADE)
Mild	Frictional keratosis, traumatic ulcer < 2 weeks, asymptomatic white patches	Oral hygiene, remove irritant, topical analgesics: Lidocaine hydrochloride 2% gel (Acuvisc®), Chlorhexidine gluconate 0.2% (Corsodyl®)	Betamethasone sodium phosphate 0.5 mg (Betnesol®) rinse, Benzydamine hydrochloride 0.15% (Difflam®) rinse	If symptoms persist > 2-3 weeks → reassess and consider biopsy	[1,2,12,19,25]	A
Moderate	Recurrent ulcers, symptomatic oral lichen planus, oral candidiasis	Clobetasol propionate 0.05% ointment (Dermovate®), Nystatin 100000 units/mL (Nystan®), Miconazole 2% oral gel (Daktarin®)	Fluconazole 50-100 mg OD, tacrolimus 0.03% ointment (Protopic®), Amitriptyline 10-25 mg nocte	Unresponsive after 2-4 weeks of compliant treatment → urgent review	[1,8,12,23,24]	A
Severe	Erythroplakia, non-healing ulcer > 3 weeks, severe pain, suspicious lesions	Urgent biopsy, clobetasol propionate (Dermovate®), systemic steroids as indicated	Multidisciplinary review, systemic immunomodulation	Urgent referral for any persistent red or red-white patch (erythroplakia/erythroleukoplakia), non-healing ulcer > 3 weeks, or unexplained lump on lip/oral cavity	[2,12,20,27,28]	A

Evidence level (GRADE): A: High; B: Moderate; C: Low. OD: Once a day; Nocte: At night.

Table 5 Supportive herbal and traditional remedies for common oral mucosal lesions: Scientific basis and use

Condition	Herbal remedy (scientific name)	Therapeutic action	Recommended use	Evidence/source	Ref.	Evidence level (GRADE)
Aphthous ulcers	Chamomile, honey, alum (shabbah is potassium aluminum sulfate), myrrh	Anti-inflammatory, antimicrobial, astringent, antiseptic	Topical application or rinse 3-4 ×/day for 7-10 days; reassess at day 10	Clinical and traditional studies	[31-35]	A
Oral lichen planus	Aloe vera, Nigella sativa (black seed oil)	Anti-inflammatory, antioxidant, epithelial repair	Apply topically twice daily for 4 weeks; reassess at week 4	RCTs and in vitro studies	[31-35]	A
Burning mouth syndrome	Capsaicin	Neuropathic desensitization	Low-concentration rinse or gel BID for 2 weeks; Review response at 14 days; off-label; use only pharmacy-compounded 0.025%-0.075% formulations	Small-scale clinical trials	[36-40]	B
Oral candidiasis	Tea tree oil	Antifungal, antiseptic	Diluted rinse 2-3 ×/day for 14 days; do not swallow	In vitro and pilot trials	[38-41]	B
General oral health	Curcumin (turmeric)	Anti-inflammatory, antioxidant	Curcumin rinse BID or 500 mg capsules daily for 4-6 weeks	Systematic reviews	[35,37]	A

Evidence level (GRADE): A: High; B: Moderate; C: Low. RCT: Randomized controlled trial; BID: Twice a day.